Opexa Therapeutics, Inc.
2635 N Crescent Ridge Drive
The Woodlands,
TX 77381
United States - Map
Phone: 281-272-9331
Fax: 281-272-1088
Web Site: http://www.opexatherapeutics.com
| Opexa Therapeutics, Inc. operates as a biopharmaceutical company, developing autologous cellular therapies with the potential to treat major illnesses, including multiple sclerosis (MS) and diabetes. These therapies are based on Opexa's proprietary T-cell and adult stem cell technologies. The companys products include a T-cell therapeutic vaccine, Tovaxin, which is in clinical development for the treatment of MS. The adult stem cell technology is in the preclinical development stage. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Neil K. Warma , 46
Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer, Sec. |
$
195.00K | N/A | Mrs. Donna R. Rill , 56
Sr. VP of Operations |
$
141.00K | N/A | Dr. Jim C. Williams , 66
Consultant |
$
225.00K | N/A | Mr. Dawn McGuire M.D., 55
Acting Chief Medical Officer and Member of Clinical Advisory Board |
N/A
| N/A | Dr. Jaye L. Thompson Ph.D.,
Sr. VP of Clinical Devel. & Regulatory Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.51% Nasdaq 
0.01 (0.50%) 
Profile
